AGA临床实践更新:难治性便秘的评估与管理专家综述
美国胃肠病协会(AGA)发布的专家综述,针对难治性便秘(RC)提出系统评估步骤:排除可纠正的继发原因(药物、神经疾病、排便障碍)、确认慢结肠传输、确保充分尝试非手术疗法。手术(结肠切除)仅用于失败者,术前需确认慢传输、排除排便障碍、评估胃排空/小肠动力及心理共病。相对禁忌包括上消化道动力障碍、未治严重精神疾病、以腹胀/腹痛为主诉。
要点
- 难治性便秘需系统排除继发原因并确认慢结肠传输。
- 手术前应确保充分药物及非药物联合治疗失败。
- 结肠切除术前需排除排便障碍并评估心理及动力。
核心结论
- 难治性便秘应系统评估继发原因、确认慢传输并确保充分内科治疗。
- 手术仅用于治疗失败者,术前需全面评估动力及心理共病。
研究设计与样本
- 由AGA临床实践更新委员会委托并批准的专家综述,经内外部同行评议。
- 基于已发表文献回顾和专家意见提出最佳实践建议,未进行系统评价。
主要发现
- 难治性便秘相对罕见,需系统排除药物、神经疾病及排便障碍等可纠正原因。
- 手术与并发症风险增加及不可忽视的不满意结局相关。
- 心理共病可能加重症状并 adversely 影响手术结局。
关键数值与推荐
- 术前必须确认慢结肠传输、排除并发排便障碍。
- 需评估胃排空或小肠动力严重症状性延迟。
- 建议术前心理评估以判断手术适宜性。
- 相对禁忌包括临床显著上消化道动力障碍、严重未治精神疾病、以腹胀和/或腹痛为主诉。
- 不确定病例可考虑临时袢式回肠造口预测结肠切除反应;结肠切除回肠直肠吻合仅用于无持续排便障碍者。
临床怎么用
- 对难治性便秘患者按步骤排除继发原因并确认慢传输。
- 确保充分尝试非处方及FDA批准药物和非药物联合治疗。
- 手术前全面评估动力、心理及排便障碍,严格掌握适应证。
局限性
- 未进行系统评价,最佳实践建议无正式证据质量或推荐强度评级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DESCRIPTION: Although most patients with chronic constipation respond to medical therapy, a subset experiences refractory constipation (RC), which poses unique diagnostic and therapeutic challenges. Because RC is relatively rare, clinicians should systematically (1) exclude correctable secondary causes such as medications, neurologic disorders, and defecatory disorders (DDs); (2) confirm the presence of slow colonic transit; and (3) ensure that patients have undergone adequate trials of over-the-counter and Food and Drug Administration-approved medications and nonpharmacologic therapies, including combinations thereof. Surgical treatments, such as colectomy, may be considered in patients who fail available treatments. However, surgical treatment of chronic constipation is associated with increased risk of complications and a not insignificant number of unsatisfactory outcomes. Prior to advising surgery, it is essential to confirm slow colonic transit, exclude concurrent DDs, and evaluate for severe, symptomatic delays in gastric emptying or small bowel dysmotility. Psychological comorbidities may exacerbate symptoms and adversely affect surgical outcomes. Hence, preoperative psychological evaluation is also advisable to assess suitability for surgery. Relative contraindications to surgical treatment of RC include clinically significant upper-gut dysmotility, severe, untreated psychiatric disease, and predominant complaints of bloating and/or abdominal pain. In uncertain cases, a temporary diverting loop ileostomy may help predict the potential response to colectomy. A colectomy with ileorectal anastomosis should only be offered to patients without ongoing DDs. METHODS: This expert review was commissioned and approved by the American Gastroenterological Association (AGA) Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Clinical Gastroenterology and Hepatology. These Best Practice Advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these Best Practice Advice statements do not carry formal ratings of the quality of evidence or strength of the presented considerations.
引用
- Staller K, Neshatian L, Lembo A, et al. AGA Clinical Practice Update on Evaluation and Management of Refractory Constipation: Expert Review. Clin Gastroenterol Hepatol. 2026. PMID: 41504675. doi:10.1016/j.cgh.2025.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。